Moreover, soluble B7 family ligands have also been detected in the sera of tumor patients; soluble B7-H3 and soluble B7-H4 have proven to be prognostic biomarkers in ovarian and renal cancer 12. This evidence concerns the gene CD80 and neoplasm.